Aroa Biosurgery Limited is a listed company. Its directors and officers file their transactions with ASX. 6 insiders have disclosed 6 filings since 18 October 2025.
All open-market trades in the period are sales: 1 sale worth €76k, by 1 insider, with no purchase on record. Biggest ticket of the year: €76k, sold and made public on 29 June 2026.
Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
For context, the typical company on the same exchange (median of 2,222 companies) published 3 filings over the same period, against 6 filings here. Over the whole record (from 2026), the tally stands at no purchases and 1 sale.
Source: insider filings from ASX. Past trades are no guide to future returns.
Analysts rate Aroa Biosurgery Limited Strong Buy (bullish), based on 3 analysts. Average price target: A$1.09.
Transparent value + quality ranking, distinct from the insider signal.
FY ended March 2026 · cache
6 of 6 declarations
Aroa Biosurgery Limited is a company focused on developing biotechnology-based healthcare solutions. It is listed on the XASX market.
Source: Wikidata (CC0).